Published in J Infect Dis on May 17, 2002
Meningococcal genetic variation mechanisms viewed through comparative analysis of serogroup C strain FAM18. PLoS Genet (2006) 2.47
Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway. J Clin Microbiol (2004) 2.41
Use of 16S rRNA gene sequencing for rapid identification and differentiation of Burkholderia pseudomallei and B. mallei. J Clin Microbiol (2003) 2.15
Molecular epidemiology of neisseria meningitidis isolated in the African Meningitis Belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes. J Clin Microbiol (2005) 1.82
Serogroup W-135 meningococcal disease during the Hajj, 2000. Emerg Infect Dis (2003) 1.81
Meningitis serogroup W135 outbreak, Burkina Faso, 2002. Emerg Infect Dis (2007) 1.75
Prospects for vaccine prevention of meningococcal infection. Clin Microbiol Rev (2006) 1.53
Meningococcal disease: changes in epidemiology and prevention. Clin Epidemiol (2012) 1.48
Sequence diversity of Neisseria meningitidis 16S rRNA genes and use of 16S rRNA gene sequencing as a molecular subtyping tool. J Clin Microbiol (2002) 1.45
Use of variable-number tandem repeats to examine genetic diversity of Neisseria meningitidis. J Clin Microbiol (2005) 1.44
A prospective study of etiology of childhood acute bacterial meningitis, Turkey. Emerg Infect Dis (2008) 1.44
Continuing diversification of Neisseria meningitidis W135 as a primary cause of meningococcal disease after emergence of the serogroup in 2000. J Clin Microbiol (2004) 1.40
Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000-2005. J Infect Dis (2010) 1.31
Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage. J Infect (2015) 1.31
Epidemiological profile of meningococcal disease in the United States. Clin Infect Dis (2010) 1.31
Molecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine. PLoS One (2012) 1.23
Neisseria meningitidis serogroup W, Burkina Faso, 2012. Emerg Infect Dis (2014) 1.22
Recombinational switching of the Clostridium difficile S-layer and a novel glycosylation gene cluster revealed by large-scale whole-genome sequencing. J Infect Dis (2012) 1.21
Molecular epidemiology and emergence of worldwide epidemic clones of Neisseria meningitidis in Taiwan. BMC Infect Dis (2006) 1.19
High level of sequence diversity in the 16S rRNA genes of Haemophilus influenzae isolates is useful for molecular subtyping. J Clin Microbiol (2005) 1.16
Molecular epidemiology of meningococci isolated in Niger in 2003 shows serogroup A sequence type (ST)-7 and serogroup W135 ST-11 or ST-2881 strains. J Clin Microbiol (2005) 1.13
Clonal spread of serogroup W135 meningococcal disease in Turkey. J Clin Microbiol (2006) 1.10
Evidence for capsule switching between carried and disease-causing Neisseria meningitidis strains. Infect Immun (2009) 1.05
The elusive meningococcal meningitis serogroup: a systematic review of serogroup B epidemiology. BMC Infect Dis (2010) 1.03
Neisseria adhesin A variation and revised nomenclature scheme. Clin Vaccine Immunol (2014) 0.99
Clonal distribution of invasive Neisseria meningitidis serogroup C strains circulating from 1976 to 2005 in greater Sao Paulo, Brazil. J Clin Microbiol (2007) 0.99
Neisseria meningitidis serogroup W135, China. Emerg Infect Dis (2010) 0.98
Disease susceptibility to ST11 complex meningococci bearing serogroup C or W135 polysaccharide capsules, North America. Emerg Infect Dis (2004) 0.98
Phenotypic and molecular characterization of invasive serogroup W135 Neisseria meningitidis strains from 1990 to 2005 in Brazil. J Infect (2010) 0.98
Clinical features and outcome of sporadic serogroup W135 disease Taiwan. BMC Infect Dis (2006) 0.96
Meningococcal disease in South Africa, 1999-2002. Emerg Infect Dis (2007) 0.95
Serologic responses to ACYW135 polysaccharide meningococcal vaccine in Saudi children under 5 years of age. Infect Immun (2005) 0.95
Capsular switching in invasive Neisseria meningitidis, Brazil(1). Emerg Infect Dis (2012) 0.94
Multilocus sequence typing of Neisseria meningitidis directly from clinical samples and application of the method to the investigation of meningococcal disease case clusters. J Clin Microbiol (2005) 0.92
Cluster of serogroup W135 meningococci, southeastern Florida, 2008-2009. Emerg Infect Dis (2010) 0.91
Genomic Epidemiology of Hypervirulent Serogroup W, ST-11 Neisseria meningitidis. EBioMedicine (2015) 0.90
Neisseria meningitidis W135, Turkey. Emerg Infect Dis (2004) 0.88
Randomized trial on the safety, tolerability, and immunogenicity of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, administered concomitantly with a combined tetanus, reduced diphtheria, and acellular pertussis vaccine in adolescents and young adults. Clin Vaccine Immunol (2010) 0.83
Description of an unusual Neisseria meningitidis isolate containing and expressing Neisseria gonorrhoeae-Specific 16S rRNA gene sequences. J Clin Microbiol (2013) 0.83
An international invasive meningococcal disease outbreak due to a novel and rapidly expanding serogroup W strain, Scotland and Sweden, July to August 2015. Euro Surveill (2016) 0.82
Spread of Neisseria meningitidis serogroup W clone, China. Emerg Infect Dis (2013) 0.82
Surface plasmon resonance analysis of antipolysaccharide antibody specificity: responses to meningococcal group C conjugate vaccines and bacteria. Infect Immun (2004) 0.82
Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine. BMC Infect Dis (2013) 0.81
Absence of Neisseria meningitidis W-135 electrophoretic Type 37 during the Hajj, 2002. Emerg Infect Dis (2003) 0.80
Using single-nucleotide polymorphisms to discriminate disease-associated from carried genomes of Neisseria meningitidis. J Bacteriol (2011) 0.80
Emergence of serogroup C meningococcal disease associated with a high mortality rate in Hefei, China. BMC Infect Dis (2012) 0.79
Genetic diversity of Neisseria meningitidis serogroup C ST-4821 in China based on multiple-locus variable number tandem repeat analysis. PLoS One (2014) 0.78
Infectious diseases epidemic threats and mass gatherings: refocusing global attention on the continuing spread of the Middle East Respiratory syndrome coronavirus (MERS-CoV). BMC Med (2016) 0.76
Is the Emergence of the N. meningitidis Serogroup W ST-11 Hajj Outbreak Unraveling in the New Era of WGS? EBioMedicine (2015) 0.75
Antimicrobial susceptibility, serotype and genotype distribution of meningococci in Portugal, 2001-2002. Epidemiol Infect (2006) 0.75
The Establishment and Diversification of Epidemic-Associated Serogroup W Meningococcus in the African Meningitis Belt, 1994 to 2012. mSphere (2016) 0.75
Travel-related Neisseria meningitidis serogroup W135 infection, France. Emerg Infect Dis (2013) 0.75
Establishment of an active laboratory-based surveillance for bacterial meningitis in Croatia and molecular characterization of Neisseria meningitidis isolates causing meningococcal disease that were collected in the year 2000, the first year of activity. J Clin Microbiol (2004) 0.75
Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science (2003) 7.49
Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis (2002) 5.23
Identification of anthrax toxin genes in a Bacillus cereus associated with an illness resembling inhalation anthrax. Proc Natl Acad Sci U S A (2004) 4.73
Characterization of encapsulated and noncapsulated Haemophilus influenzae and determination of phylogenetic relationships by multilocus sequence typing. J Clin Microbiol (2003) 4.47
Fatal inhalational anthrax in a 94-year-old Connecticut woman. JAMA (2002) 3.26
NadA, a novel vaccine candidate of Neisseria meningitidis. J Exp Med (2002) 3.26
Characterization of Bacillus cereus isolates associated with fatal pneumonias: strains are closely related to Bacillus anthracis and harbor B. anthracis virulence genes. J Clin Microbiol (2006) 3.15
Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol (2009) 3.14
Molecular subtyping of Bacillus anthracis and the 2001 bioterrorism-associated anthrax outbreak, United States. Emerg Infect Dis (2002) 2.99
Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment. Lancet Infect Dis (2013) 2.95
Spread of drug-resistant Mycobacterium tuberculosis strains of the Beijing genotype in the Archangel Oblast, Russia. J Clin Microbiol (2002) 2.92
Investigations of 2 cases of diphtheria-like illness due to toxigenic Corynebacterium ulcerans. Clin Infect Dis (2008) 2.73
Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger. Clin Infect Dis (2007) 2.70
Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences. Proc Natl Acad Sci U S A (2014) 2.63
Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity. Clin Infect Dis (2012) 2.62
Neisseria meningitidis: an overview of the carriage state. J Med Microbiol (2004) 2.61
Sequencing of 16S rRNA gene: a rapid tool for identification of Bacillus anthracis. Emerg Infect Dis (2002) 2.54
Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway. J Clin Microbiol (2004) 2.41
Leptospirosis in "Eco-Challenge" athletes, Malaysian Borneo, 2000. Emerg Infect Dis (2003) 2.35
Improving global public health leadership through training in epidemiology and public health: the experience of TEPHINET. Training Programs in Epidemiology and Public Health Interventions Network. Am J Public Health (2002) 2.25
Multilocus sequence typing scheme for bacteria of the Bacillus cereus group. Appl Environ Microbiol (2004) 2.24
Evaluation and validation of a real-time polymerase chain reaction assay for rapid identification of Bacillus anthracis. Emerg Infect Dis (2002) 2.23
Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidis. J Clin Microbiol (2004) 2.20
Use of 16S rRNA gene sequencing for rapid identification and differentiation of Burkholderia pseudomallei and B. mallei. J Clin Microbiol (2003) 2.15
Pathology and pathogenesis of bioterrorism-related inhalational anthrax. Am J Pathol (2003) 2.11
Surface sampling methods for Bacillus anthracis spore contamination. Emerg Infect Dis (2002) 2.11
Application of TaqMan low-density arrays for simultaneous detection of multiple respiratory pathogens. J Clin Microbiol (2011) 2.07
Outbreak of leptospirosis among triathlon participants and community residents in Springfield, Illinois, 1998. Clin Infect Dis (2002) 2.02
Epidemiology of invasive Haemophilus influenzae type A disease among Navajo and White Mountain Apache children, 1988-2003. Clin Infect Dis (2005) 2.01
Use of 16S rRNA gene sequencing for rapid confirmatory identification of Brucella isolates. J Clin Microbiol (2004) 1.97
Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis. J Infect Dis (2009) 1.92
The scientific basis for law as a public health tool. Am J Public Health (2008) 1.91
Antimicrobial susceptibility testing of Bacillus anthracis: comparison of results obtained by using the National Committee for Clinical Laboratory Standards broth microdilution reference and Etest agar gradient diffusion methods. J Clin Microbiol (2002) 1.83
Molecular epidemiology of neisseria meningitidis isolated in the African Meningitis Belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes. J Clin Microbiol (2005) 1.82
Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience. Vaccine (2012) 1.81
Serogroup W-135 meningococcal disease during the Hajj, 2000. Emerg Infect Dis (2003) 1.81
Continued low rates of transmission of Mycobacterium tuberculosis in Norway. J Clin Microbiol (2003) 1.81
Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates in the Archangel prison in Russia: predominance of the W-Beijing clone family. Clin Infect Dis (2003) 1.78
Mutator clones of Neisseria meningitidis in epidemic serogroup A disease. Proc Natl Acad Sci U S A (2002) 1.77
Meningitis serogroup W135 outbreak, Burkina Faso, 2002. Emerg Infect Dis (2007) 1.75
Seropositivity to Chlamydia pneumoniae is associated with risk of first ischemic stroke. Stroke (2006) 1.70
Clinical features and outcome of pediatric Neisseria meningitidis serogroup W135 infection: a report of 5 cases. Clin Infect Dis (2004) 1.69
The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005. Clin Infect Dis (2006) 1.66
Tracking airborne Legionella and Legionella pneumophila at a biological treatment plant. Environ Sci Technol (2008) 1.58
From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreak. Lancet Infect Dis (2011) 1.58
Down-regulation of pili and capsule of Neisseria meningitidis upon contact with epithelial cells is mediated by CrgA regulatory protein. Mol Microbiol (2002) 1.57
Interlaboratory comparison of PCR-based identification and genogrouping of Neisseria meningitidis. J Clin Microbiol (2005) 1.56
Impact of a pneumococcal conjugate vaccination program on carriage among children in Norway. Clin Vaccine Immunol (2010) 1.54
A two-component direct fluorescent-antibody assay for rapid identification of Bacillus anthracis. Emerg Infect Dis (2002) 1.54
Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway. Vaccine (2008) 1.53
Bacillus anthracis aerosolization associated with a contaminated mail sorting machine. Emerg Infect Dis (2002) 1.52
Identification of Haemophilus influenzae serotypes by standard slide agglutination serotyping and PCR-based capsule typing. J Clin Microbiol (2003) 1.50
An overview of adverse events reported by participants in CDC's anthrax vaccine and antimicrobial availability program. Pharmacoepidemiol Drug Saf (2005) 1.50
Specificity of four laboratory approaches for cross-sectional HIV incidence determination: analysis of samples from adults with known nonrecent HIV infection from five African countries. AIDS Res Hum Retroviruses (2012) 1.50
Circulating Chlamydia pneumoniae DNA and advanced coronary artery disease. Int J Cardiol (2006) 1.48
Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine. Clin Vaccine Immunol (2011) 1.47
Assessing the risk of laboratory-acquired meningococcal disease. J Clin Microbiol (2005) 1.47
Public health in the time of bioterrorism. Emerg Infect Dis (2002) 1.46
Bacterial diversity in aortic aneurysms determined by 16S ribosomal RNA gene analysis. J Vasc Surg (2006) 1.45
Sequence diversity of Neisseria meningitidis 16S rRNA genes and use of 16S rRNA gene sequencing as a molecular subtyping tool. J Clin Microbiol (2002) 1.45
Use of variable-number tandem repeats to examine genetic diversity of Neisseria meningitidis. J Clin Microbiol (2005) 1.44
Deciphering an outbreak of drug-resistant Mycobacterium tuberculosis. J Clin Microbiol (2003) 1.43
Nucleic acid-based methods for the detection of bacterial pathogens: present and future considerations for the clinical laboratory. Clin Chim Acta (2005) 1.43
Recent increase in meningitis Caused by Neisseria meningitidis serogroups A and W135, Yaoundé, Cameroon. Emerg Infect Dis (2002) 1.42
The role of particular strains of Neisseria meningitidis in meningococcal arthritis, pericarditis, and pneumonia. Clin Infect Dis (2003) 1.41
Analysis of genetic relatedness of Haemophilus influenzae isolates by multilocus sequence typing. J Bacteriol (2007) 1.41
NadA diversity and carriage in Neisseria meningitidis. Infect Immun (2004) 1.40
Impact of drug resistance on fitness of Mycobacterium tuberculosis strains of the W-Beijing genotype. FEMS Immunol Med Microbiol (2004) 1.36
Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002. Clin Infect Dis (2006) 1.36
First case of bioterrorism-related inhalational anthrax in the United States, Palm Beach County, Florida, 2001. Emerg Infect Dis (2002) 1.34
Preliminary evaluation of the API 20NE and RapID NF plus systems for rapid identification of Burkholderia pseudomallei and B. mallei. J Clin Microbiol (2005) 1.31
Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000-2005. J Infect Dis (2010) 1.31
Effects of long-term storage on plasmid stability in Bacillus anthracis. Appl Environ Microbiol (2005) 1.30
Detection of fungal DNA in human body fluids and tissues during a multistate outbreak of fungal meningitis and other infections. Eukaryot Cell (2013) 1.30
Paracoccus yeeii sp. nov. (formerly CDC group EO-2), a novel bacterial species associated with human infection. J Clin Microbiol (2003) 1.29
Transgenic mice expressing human transferrin as a model for meningococcal infection. Infect Immun (2007) 1.28
Meningococcal factor H binding proteins in epidemic strains from Africa: implications for vaccine development. PLoS Negl Trop Dis (2011) 1.27
Epidemiological changes in meningococcal meningitis in Niger from 2008 to 2011 and the impact of vaccination. BMC Infect Dis (2013) 1.27
Mycobacterium tuberculosis mammalian cell entry operon (mce) homologs in Mycobacterium other than tuberculosis (MOTT). FEMS Immunol Med Microbiol (2002) 1.26
Preliminary laboratory report of fungal infections associated with contaminated methylprednisolone injections. J Clin Microbiol (2013) 1.25